|
1
|
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
|
N Engl J Med
|
2002
|
5.58
|
|
2
|
A single cycle of rituximab for the treatment of severe pemphigus.
|
N Engl J Med
|
2007
|
2.41
|
|
3
|
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
|
Arch Dermatol
|
2007
|
2.00
|
|
4
|
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study.
|
J Invest Dermatol
|
2007
|
1.41
|
|
5
|
Sweet's syndrome after BCG vaccination.
|
Acta Derm Venereol
|
2002
|
1.41
|
|
6
|
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
|
J Invest Dermatol
|
2009
|
1.26
|
|
7
|
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
|
J Invest Dermatol
|
2010
|
1.22
|
|
8
|
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.
|
Sci Transl Med
|
2013
|
1.15
|
|
9
|
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.
|
Clin Gastroenterol Hepatol
|
2010
|
1.15
|
|
10
|
Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
|
J Clin Oncol
|
2008
|
1.15
|
|
11
|
Neurological disorders in patients with bullous pemphigoid.
|
Dermatology
|
2007
|
1.14
|
|
12
|
Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
|
J Allergy Clin Immunol
|
2008
|
0.94
|
|
13
|
Induction of apoptosis-like mitochondrial impairment triggers antioxidant and Bcl-2-dependent keratinocyte differentiation.
|
J Invest Dermatol
|
2005
|
0.92
|
|
14
|
Pulmonary manifestations of Pyoderma gangrenosum.
|
Presse Med
|
2007
|
0.88
|
|
15
|
Skin side effects of inflammatory bowel disease therapy.
|
Inflamm Bowel Dis
|
2013
|
0.87
|
|
16
|
Prognostic factors of paraneoplastic pemphigus.
|
Arch Dermatol
|
2012
|
0.85
|
|
17
|
Phylogenetic analysis of Trichophyton mentagrophytes human and animal isolates based on MnSOD and ITS sequence comparison.
|
Microbiology
|
2007
|
0.85
|
|
18
|
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.
|
Arthritis Rheum
|
2008
|
0.82
|
|
19
|
[Radiation-induced skin reactions (except malignant tumors)].
|
Bull Cancer
|
2003
|
0.80
|
|
20
|
Detection of an intragenic deletion expands the spectrum of CTSC mutations in Papillon-Lefèvre syndrome.
|
J Invest Dermatol
|
2007
|
0.79
|
|
21
|
Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
|
J Crohns Colitis
|
2011
|
0.77
|
|
22
|
Toxic epidermal necrolysis caused by tetrazepam.
|
Int J Dermatol
|
2006
|
0.77
|
|
23
|
Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: seronegative antiphospholipid-like syndrome.
|
J Am Acad Dermatol
|
2009
|
0.76
|
|
24
|
Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
|
Arch Dermatol
|
2012
|
0.76
|
|
25
|
Eosinophils and urticaria.
|
Clin Rev Allergy Immunol
|
2006
|
0.75
|
|
26
|
Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases.
|
J Am Acad Dermatol
|
2013
|
0.75
|
|
27
|
[Acute necrotic alcoholic pancreatitis with Cullen and Grey Turner signs].
|
Gastroenterol Clin Biol
|
2005
|
0.75
|
|
28
|
Eyelid dermatitis with positive patch test to coconut diethanolamide.
|
Contact Dermatitis
|
2005
|
0.75
|
|
29
|
[Carcinosarcoma of the scalp].
|
Ann Pathol
|
2002
|
0.75
|
|
30
|
Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
|
Inflamm Bowel Dis
|
2016
|
0.75
|
|
31
|
A four-year history of pruriginous erythroderma leading to the diagnosis of idiopathic hypereosinophilic syndrome.
|
Acta Derm Venereol
|
2002
|
0.75
|
|
32
|
|
Swiss Dent J
|
2017
|
0.75
|
|
33
|
[Treatment of chronic lupus erythematosus with sulfasalazine in 18 patients: reappraisal].
|
Presse Med
|
2006
|
0.75
|
|
34
|
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
|
Arch Dermatol
|
2009
|
0.75
|